HAYMAN CAPITAL MANAGEMENT, L.P.
Follow13F filer, CIK 1420192, Dallas, TX
HAYMAN CAPITAL MANAGEMENT, L.P. reported $80,152,000 across 3 holdings for the quarter ended 2015-12-31, in a 13F-HR filed 2016-02-16.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000950123-16-014676
- Period
- 2015-12-31
- Reported value
- $80.2M
- Holdings
- 3
- Top 10 weight
- 100%
- New
- 0
- Sold out
- 11
Largest buys vs the previous quarter
None.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| IMPAX LABORATORIES INCexited | -606,618 | -$21.4M |
| CFexited | -464,101 | -$20.8M |
| GW PHARMACEUTICALS PLCexited | -210,715 | -$19.3M |
| BMRNexited | -129,501 | -$13.6M |
| VRTXexited | -100,000 | -$10.4M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q4 2015
Share positions as resolved from 13F-HR 0000950123-16-014676, largest first. % of portfolio is the value over $56,572,000, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| NMIHNMI HLDGS INC | 7,371,500 | $49.9M | 88.22% | 0 | Timeline | ||
| ECO STIM ENERGY SOLUTIONS INECO STIM ENERGY SOLUTIONS IN | 2,130,000 | $6.67M | 11.78% | 0 |
Options
Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).
| Security | Type | Amount | Value | Change |
|---|---|---|---|---|
| YPFYPF SOCIEDAD ANONIMA SPON ADR CL D | call | 1,500,000 | $23.6M | -750,000 |
Sold out in Q4 2015
Positions in the previous quarter's report that this quarter's report no longer lists.
| Security | Shares before | Value before | Type |
|---|---|---|---|
| IMPAX LABORATORIES INCIMPAX LABORATORIES INC | 606,618 | $21.4M | shares |
| CFCF INDUSTRIES HOLD | 464,101 | $20.8M | shares |
| GW PHARMACEUTICALS PLCGW PHARMACEUTICALS PLC | 210,715 | $19.3M | shares |
| BMRNBIOMARIN PHARMACEUTICAL INC | 129,501 | $13.6M | shares |
| VRTXVERTEX PHARMACEUTICALS INC | 100,000 | $10.4M | shares |
| DBV TECHNOLOGIES S ADBV TECHNOLOGIES S A | 265,376 | $9.45M | shares |
| Sierra Oncology, Inc.Sierra Oncology, Inc. | 422,200 | $8.66M | shares |
| ALLERGAN PLCALLERGAN PLC | 17,813 | $4.84M | shares |
| Alcobra LtdAlcobra Ltd | 625,792 | $3.78M | shares |
| ENDO INTL PLCENDO INTL PLC | 52,634 | $3.65M | shares |
| MYLAN NVMYLAN NV | 78,905 | $3.18M | shares |
How Q4 2015 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0000950123-16-014676 | base | 2016-02-16 | acceptance time not in the bulk data set |